1. Home
  2. CORT vs FIVE Comparison

CORT vs FIVE Comparison

Compare CORT & FIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • FIVE
  • Stock Information
  • Founded
  • CORT 1998
  • FIVE 2002
  • Country
  • CORT United States
  • FIVE United States
  • Employees
  • CORT N/A
  • FIVE N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • FIVE Department/Specialty Retail Stores
  • Sector
  • CORT Health Care
  • FIVE Consumer Discretionary
  • Exchange
  • CORT Nasdaq
  • FIVE Nasdaq
  • Market Cap
  • CORT 7.5B
  • FIVE 7.1B
  • IPO Year
  • CORT N/A
  • FIVE 2012
  • Fundamental
  • Price
  • CORT $72.98
  • FIVE $132.75
  • Analyst Decision
  • CORT Strong Buy
  • FIVE Buy
  • Analyst Count
  • CORT 4
  • FIVE 19
  • Target Price
  • CORT $142.00
  • FIVE $115.94
  • AVG Volume (30 Days)
  • CORT 1.6M
  • FIVE 1.5M
  • Earning Date
  • CORT 07-28-2025
  • FIVE 08-27-2025
  • Dividend Yield
  • CORT N/A
  • FIVE N/A
  • EPS Growth
  • CORT 8.36
  • FIVE N/A
  • EPS
  • CORT 1.14
  • FIVE 4.78
  • Revenue
  • CORT $685,446,000.00
  • FIVE $4,035,191,000.00
  • Revenue This Year
  • CORT $35.83
  • FIVE $16.13
  • Revenue Next Year
  • CORT $35.24
  • FIVE $9.97
  • P/E Ratio
  • CORT $63.26
  • FIVE $27.72
  • Revenue Growth
  • CORT 30.93
  • FIVE 10.71
  • 52 Week Low
  • CORT $29.42
  • FIVE $52.38
  • 52 Week High
  • CORT $117.33
  • FIVE $137.30
  • Technical
  • Relative Strength Index (RSI)
  • CORT 49.68
  • FIVE 69.77
  • Support Level
  • CORT $68.52
  • FIVE $128.53
  • Resistance Level
  • CORT $75.95
  • FIVE $134.32
  • Average True Range (ATR)
  • CORT 2.66
  • FIVE 3.79
  • MACD
  • CORT -0.13
  • FIVE -0.49
  • Stochastic Oscillator
  • CORT 42.13
  • FIVE 86.53

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About FIVE Five Below Inc.

Five Below Inc is a specialty value retailer offering merchandise targeted at the tween and teen demographic. The Company's edited assortment of products includes select brands and licensed merchandise. It derives revenue from sales of the Company's merchandise to customers.

Share on Social Networks: